DOD – Tuberous Sclerosis Complex Research Program (TSCRP) – Full Application

Well-being, Health and Biomedical Discovery

Deadlines

Academic Unit: Inquire with unit

Memorial Deadline: Monday 3rd, August 2026

External Deadline: Thursday 6th, August 2026


Description

Clinical Translational Research Award
The CTRA supports studies that will move promising, well-founded preclinical and/or clinical
research findings closer to clinical application, including diagnosis, prognosis or treatment of
TSC.

  • Exploration-Hypothesis Development Award
    The Exploration-Hypothesis Development Award (EHDA) supports the initial exploration of
    innovative, high-risk, high-gain and potentially groundbreaking concepts in the TSC research
    field. The studies supported by this award mechanism are expected to generate preliminary
    data for future avenues of scientific investigation.
  • Idea Development Award
    The IDA promotes ideas that have the potential to yield high-impact findings and new avenues
    of investigation. This award mechanism supports conceptually innovative research that could
    ultimately lead to critical discoveries in TSC research and/or improvements in patient care.
    Research projects should include a well-formulated, testable hypothesis based on strong
    preliminary data and scientific rationale.

To view the TSCRP funding opportunity announcements and submit a pre-application, visit https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=713103

Pre-Application Due: July 23, 2026
Application Due: August 6, 2026


Funding Sources

Department of Defence - United States of America



This opportunity was posted by: RGCS

Last modified: May 8, 2026